In order to examine the potential role of bacterial collagenases in periodontal tissue destruction, we recently isolated a gene, prtC, from Porphyromonas gingivalis ATCC 53977, which expressed collagenase activity (N. Takahashi, T. Kato, and H. K. Kuramitsu, FEMS Microbiol. Lett. 84:135-138, 1991). The nucleotide sequence of the gene has been determined, and the deduced amino acid sequence corresponds to a basic protein of 37.8 kDa. In addition, Southern blot analysis indicated that the prtC gene is conserved among the three major serotypes of P. gingivalis. The enzyme has been purified to near homogeneity from Escherichia coli clone NTS1
Preliminary evidence for the existence of a second collagenase expressed by strain 53977 was also obtained.
Porphyromonas gingivalis, a gram-negative anaerobic rod-shaped bacterium, has been isolated from the lesions of advanced adult periodontitis (35, 45) and has been implicated as a periodontal pathogen (20, 38, 47) . These organisms exhibit a number of potential virulence traits, including high proteolytic activity (15) . The proteases from P. gingivalis may degrade periodontal tissues (36, 40, 46) as well as inactivate host defense mechanisms (6, 31, 43) . Since type I collagen serves as a major supporting structure for the teeth, it may be particularly relevant that these organisms exhibit collagenase activity (10, 46) . This activity appears to be localized primarily in the membrane fraction of these organisms (28) , but the enzymes have not yet been purified to homogeneity and extensively characterized. However, since the collagenase activity detected in the gingival fluid from diseased sites appears to be primarily of human origin (12, 15) , there is no direct evidence that bacterial collagenases play a role in periodontal diseases.
In order to investigate the potential role of P. gingivalis collagenases in periodontitis, we have recently isolated the prtC gene which expressed collagenase activity from P. gingivalis ATCC 53977 (44) . Although extensive biochemical characterization of the collagenase activity from Clostridium histolyticum has been carried out (32) , little molecular genetic characterization of the bacterial enzymes has been reported. In contrast, both the isolation and sequence characterization of a number of different eucaryotic collagenase genes has been described (11) . In addition, except for some partial sequence data for a collagenase isolated from Vibrio alginolyticus (9) , no information is presently available regarding the nucleotide sequences of the bacterial enzymes.
In the present communication, we report the sequence analysis and further characterization of a purified collage-* Corresponding author. nase expressed from the prtC gene of P. gingivalis. To our knowledge, this information represents the first report of the complete sequence of a bacterial collagenase gene. These results are discussed in light of the potential role of the collagenase in P. gingivalis virulence.
MATERIALS AND METHODS
Bacteria and growth conditions. Escherichia coli NTS1 containing plasmid pSl was grown and maintained in LB broth supplemented with ampicillin (50 ,ug/ml) at 30°C as previously described (44) . P. gingivalis strains were maintained anaerobically on blood agar plates containing mycoplasma broth (BBL Microbiology Systems, Cockeysville, Md.) supplemented with 1.5% agar, 10% sheep blood, hemin (5 ,ug/ml), and menadione (1 ,ug/ml). P. gingivalis strains were grown anaerobically in mycoplasma broth supplemented with hemin (5 ,ug/ml) and menadione (1 ,g/ml).
Nucleotide sequencing of the prtC gene. For nucleotide sequence determination, overlapping DNA fragments from plasmid pSl were subcloned into M13 mpl8 and M13 mpl9. Single-stranded template DNA was isolated by the procedure of Messing (23 Enzyme assays. Collagenase activity was determined by an assay system using 3H-labeled reconstituted fibrillar type I collagen (specific activity, 0.020 GBq/mg; New England Nuclear, Boston, Mass.) as described by the supplier. Incubation was performed at 22°C for 3 h. In this system, collagenolytic activity is monitored by quantitating the production of soluble radioactive collagen fragments, which are readily separated from undigested collagen fibrils by centrifugation. Units of enzyme were defined by using the collagenase from C. histolyticum (315 U/mg; Sigma, St. Louis, Mo.) as a standard. In addition, collagenase activity was assayed as previously described (44) by incubating the enzymes with type I collagen (Sigma) at 30°C for 24 h. Reaction mixtures were then analyzed by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (19, 44) . The ability to hydrolyze azocoll and the synthetic collagenase substrate PZ-PLGPA (4-phenylazobenzyl-oxycarbonyl-ProLeu-Gly-Pro-D-Arg) were examined by utilizing standard assay procedures (4, 48) . Gelatinase activity was determined by the X-ray film method (26) .
Purified cystatin SA-I was obtained from M. J. Levine (State University of New York, Buffalo), and histatin 5 was obtained from Y. Kuboki (Hokkaido University, Sapporo, Japan).
Nucleotide sequence accession number. The nucleotide sequence of the prtC gene has been deposited in the GenBank data base and given the accession number M60404.
RESULTS
Sequence analysis of the prtC gene. Recently, the prtC gene coding for collagenase activity was isolated on a 5.9-kb DNA fragment from P. gingivalis ATCC 53977 cloned into plasmid vector pPL-lambda (44) . Since deletion analysis and subcloning indicated that the gene was located at one end of the insert, overlapping DNA fragments from this region were utilized to determine the nucleotide sequences of both DNA strands. A single long open reading frame was identified in this region ( Fig. 1) (Fig. 4) . This size corresponds to the predicted size of 37.8 kDa determined following nucleotide sequencing. In addition, the collagenase activity displayed an apparent molecular size of 70 kDa on the gel filtration column (data not shown). Therefore, it appears that the enzyme behaves as a dimer in its native form.
The purified enzyme degraded soluble (Fig. 5) as well as fibrillar reconstituted type I collagen (Table 1) , azocoll, and heat-denatured (boiled for 5 or 10 min) type I collagen.
However, the enzyme did not hydrolyze gelatin or the synthetic bacterial collagenase substrate PZ-PLGPA (data not shown). Therefore, the P. gingivalis collagenase appears to display properties which are distinct from those of other bacterial collagenases (18, 41) . In addition, unlike eucaryotic collagenases (32), the P. gingivalis collagenase did not yield distinct degradation products when it was analyzed at different time periods (Fig. 5) . It is likely that the purified enzyme degrades type I collagen to small peptide fragments which migrate off of the SDS-PAGE gel.
The purified collagenase is slightly stimulated in the presence of Ca2+ but is strongly inhibited by Zn2+ and Fe3+ (Table 2) . Neither Mg2' nor Mn2+ significantly affected enzyme activity. The enzyme appears to contain essential sulfhydryl groups, since p-chloromercuribenzoic acid is a strong inhibitor of the collagenase activity (Table 3) . However, reducing agents such as 2-mercaptoethanol and dithiothreitol did not enhance enzyme activity, as has been observed for many enzymes from anaerobic bacteria (8, 14, 27, 39, 49 Evidence for two collagenases expressed by strain 53977. When crude extracts of P. gingivalis ATCC 53977 were subjected to anion exchange chromatography on Mono Q columns (Fig. 6) , two peaks of collagenase activity could be detected. The active fractions not retained by the column contained a protein of approximately 35 kDa as detected following SDS-PAGE (data not shown) and therefore appears to correspond to the product of the prtC gene. However, a second collagenase activity was retained by the column and was eluted with the salt gradient. This enzyme fraction did not display a 35-kDa protein when subjected to SDS-PAGE. Therefore, these results are consistent with the presence of at least two collagenase enzymes produced by strain 53977.
DISCUSSION
The recently isolated prtC gene was shown to express an enzyme which hydrolyzes soluble type I collagen (44) . The present investigation revealed that the collagenase was also capable of degrading reconstituted fibrillar collagen similar to the enzyme extensively characterized from C. histolyticum (32). However, unlike the latter enzyme, the P. gingivalis collagenase did not hydrolyze the synthetic collagenase substrate PZ-PLGPA. Likewise, unlike most collagenases (17, 18, 32, 41) , theprtC gene product did not degrade gelatin but could hydrolyze the more extensively denatured type I collagen. The reasons for this difference in substrate specificity for the collagenase is presently unknown. Additional investigation will be required to determine the cleavage specificity of the P. gingivalis enzyme. In addition, the prtC gene product exhibited no structural similarity with eucaryotic collagenases and did not contain the HELGH peptide consensus sequence found in these enzymes (11) . Likewise, degradation of type I collagen by the P. gingivalis enzyme resulted in multiple cleavage products (Fig. 5) rather than the two distinct peptides generated by the action of mammalian collagenases (24, 32) . Therefore, the properties of the prtC gene product suggest that the encoded collagenase is a unique enzyme. However, since no other bacterial collagenase has yet been completely sequenced, the P. gingivalis enzyme could be related to some of these enzymes (18, 32, 41) .
Sequence analysis of theprtC gene revealed two potential ORFs which differed by only three amino acids in length. Hydrophobicity analysis revealed that the amino-terminal sequences of both putative proteins were relatively hydrophobic (data not shown). Therefore, it may be possible that these sequences represent a signal peptide-like structure and (5, 27) . Therefore, it will be of great interest to identify the genes which are cotranscribed with the prtC gene and examine the regulation of this potential virulencerelated mRNA. Experiments addressing this issue are currently in progress in our laboratory.
Since P. gingivalis is present in the human oral cavity, it was of interest to examine the effects of potential salivary inhibitors on its collagenase activity. It has been reported that the trypsinlike protease of P. gingivalis could be inhibited by the salivary peptide histatin (25) and that this peptide also inhibited the C. histolyticum collagenase. Likewise, this peptide produced moderate inhibition of the prtC gene product (Table 3) . Another salivary peptide, cystatin SA-I, has been demonstrated to inhibit thiol-dependent proteases (1) . Since the prtC gene product is not dependent upon reducing agents (Table 3) , it was not surprising that cystatin did not act as an inhibitor of collagenase activity. In contrast, moderate stimulation of activity was demonstrated. This effect does not appear to be dependent upon the high cysteine content of cystatin, since both 2-mercaptoethanol and dithiothreitol did not stimulate activity.
The results of this study have also suggested the presence of two distinct collagenases produced by strain 53977. A recent report has suggested that a P. gingivalis trypsinlike protease displayed collagenase activity (40) . Since this latter enzyme both is thiol dependent and appears to have a larger molecular size than theprtC gene product, it may be possible that this enzyme is responsible for the collagenase activity which is retained by Mono Q columns. However, this latter enzyme has not been extensively characterized either genetically or enzymatically.
P. gingivalis strains have been utilized in experimental animal models to demonstrate virulence (13, 16, 21, 37) . A spontaneous mutant of strain W50 was isolated and demonstrated to be less virulent in a rodent model system (22) . This mutant, W50/BE1, was shown to be defective in several potential virulence characteristics, including collagenase activity (33) . However, the present investigation suggests that the loss of virulence in the mutant does not result from extensive rearrangement of the prtC gene.
The isolation of the prtC gene will make it possible to construct P. gingivalis mutants which are defective in this gene for testing in appropriate animal model systems. The recent development of a P. gingivalis gene transfer system for inactivating cloned genes in these organisms on the basis of conjugation (5a) will make it possible to construct such mutants. In this manner, it should be possible to define the potential role of the prtC in the virulence of these periodontopathogenic organisms.
